Scotland · NHS Scotland MSAN
Semaglutide (Ozempic®) 0.25mg, 0.5mg and 1mg solution for injection in a pre-
MSAN(2024)9 · Level 3 · issued 19 Mar 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Semaglutide (Ozempic®) 0.5mg solution for injection in a pre-filled pen is out of stock until | Out of stock | — |
| Semaglutide (Rybelsus®) 3mg, 7mg and 14mg tablets are available and can support | Available | — |
| pen are available but will have intermittent supply throughout 2024. New patient initiations | Available | — |
| Liraglutide (Victoza®) 6mg/ml solution for injection in a pre-filled pen is out of stock until end | Out of stock | end |
| discontinued at the end of March 2024. | Discontinued | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.